A detailed history of Yousif Capital Management, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Yousif Capital Management, LLC holds 1,633 shares of ALNY stock, worth $409,850. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,633
Previous 1,613 1.24%
Holding current value
$409,850
Previous $391,000 14.83%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$233.81 - $287.01 $4,676 - $5,740
20 Added 1.24%
1,633 $449,000
Q2 2024

Jul 31, 2024

SELL
$143.31 - $247.0 $3,152 - $5,434
-22 Reduced 1.35%
1,613 $391,000
Q1 2024

Apr 26, 2024

BUY
$146.51 - $198.2 $21,097 - $28,540
144 Added 9.66%
1,635 $244,000
Q4 2023

Feb 01, 2024

BUY
$151.41 - $196.57 $6,813 - $8,845
45 Added 3.11%
1,491 $285,000
Q3 2023

Oct 30, 2023

BUY
$170.77 - $211.65 $6,830 - $8,466
40 Added 2.84%
1,446 $256,000
Q2 2023

Aug 02, 2023

SELL
$185.01 - $212.05 $3,885 - $4,453
-21 Reduced 1.47%
1,406 $267,000
Q1 2023

May 02, 2023

BUY
$182.66 - $235.53 $9,133 - $11,776
50 Added 3.63%
1,427 $285,000
Q4 2022

Jan 09, 2023

BUY
$185.53 - $241.31 $45,454 - $59,120
245 Added 21.64%
1,377 $0
Q3 2022

Nov 04, 2022

BUY
$138.54 - $232.0 $156,827 - $262,624
1,132 New
1,132 $227,000
Q2 2022

Aug 01, 2022

SELL
$120.42 - $169.29 $210,855 - $296,426
-1,751 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$127.18 - $173.91 $8,902 - $12,173
70 Added 4.16%
1,751 $286,000
Q4 2021

Jan 31, 2022

BUY
$159.56 - $209.29 $268,220 - $351,816
1,681 New
1,681 $285,000

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.9B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.